Reaching the third 95 using community ART delivery models

Affiliations

Comment

Mwangelwa Mubiana-Mbewe. Lancet HIV. 2022 Jan.

. 2022 Jan;9(1):e2-e3.

doi: 10.1016/S2352-3018(21)00271-X. Epub 2021 Nov 26.

¹ Centre for Infectious Disease in Zambia, Lusaka, Zambia. Electronic address: mwangelwa.mbewe@cidrz.org.

No abstract available

Conflict of interest statement

I declare no competing interests.

Rates of viral suppression in a cohort of people with stable HIV from two community models of ART delivery versus facility-based HIV care in Lusaka, Zambia: a cluster-randomised, non-inferiority trial nested in the HPTN 071 (PopART) trial.
Limbada M, Macleod D, Situmbeko V, Muhau E, Shibwela O, Chiti B, Floyd S, Schaap AJ, Hayes R, Fidler S, Ayles H; HPTN 071 (PopART) study team. Limbada M, et al. Lancet HIV. 2022 Jan;9(1):e13-e23. doi: 10.1016/S2352-3018(21)00242-3. Epub 2021 Nov 26. Lancet HIV. 2022. PMID: 34843674 Free PMC article. Clinical Trial.